Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jaguar Animal Health ( (JAGX) ) just unveiled an update.
On August 14, 2025, Jaguar Health, Inc. announced an amendment to its At the Market Offering Agreement, extending Lucid Capital Markets, LLC’s role as a Manager until December 31, 2025. This amendment, filed with the SEC, ensures that Lucid will continue its managerial role alongside Ladenburg Thalmann & Co. Inc. until the end of 2025, after which Ladenburg will become the sole Manager unless further extended.
Spark’s Take on JAGX Stock
According to Spark, TipRanks’ AI Analyst, JAGX is a Neutral.
Jaguar Animal Health’s overall stock score is primarily impacted by its weak financial performance, characterized by high leverage and consistent losses. While there are promising developments in medical research and a recent capital raise, these are overshadowed by the company’s operational and financial challenges.
To see Spark’s full report on JAGX stock, click here.
More about Jaguar Animal Health
Average Trading Volume: 98,896
Technical Sentiment Signal: Sell
Current Market Cap: $4.5M
For an in-depth examination of JAGX stock, go to TipRanks’ Overview page.